BeStock  
Stocks › Medical Devices › PRCT

PROCEPT BioRobotics PRCT

US equityMarket cap rank #3227Medical DevicesRobotics
$17.91 +$0.40 (+2.28%)
Pre-market · Oct 8, 9:00 am ET · After hours $17.91 0.00%
Open$17.63
Prev close$17.51
Day range$17.63 – $18.46
Volume1.15M
Market cap$1.03B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±10.9%last 16 reports
Closed higher7 of 1644% of the time
Best reaction+32.3%
Worst reaction-25.3%

Stock move on the day after each report

+18.4%2023/Q3-2.7%2023/Q4+1.9%2024/Q1-7.5%2024/Q2+32.3%2024/Q3+8.6%2024/Q4-5.6%2025/Q1-13.4%2025/Q2-9.7%2025/Q3-15.1%2025/Q4+10.7%2026/Q1+5.8%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q24 Aug 2026After Market±18.1%+5.80%Within range
2026/Q129 Apr 2026None±18.8%+10.73%Within range
2025/Q425 Feb 2026None±17.4%-15.12%Within range
2025/Q34 Nov 2025After Market±19.7%-9.74%Within range
2025/Q26 Aug 2025After Market±15.9%-13.35%Within range
2025/Q124 Apr 2025Pre Market±19.9%-5.64%Within range
2024/Q425 Feb 2025After Market±21.1%+8.61%Within range
2024/Q328 Oct 2024Pre Market±23.9%+32.33%Bigger than priced
2024/Q21 Aug 2024After Market±28.5%-7.45%Within range
2024/Q11 May 2024After Market±10.8%+1.86%Within range
2023/Q427 Feb 2024After Market±18.3%-2.68%Within range
2023/Q31 Nov 2023After Market±18.7%+18.37%Within range
2023/Q227 Jul 2023Pre Market±22.4%-7.14%Within range
2023/Q127 Apr 2023Pre Market±12.0%-25.31%Bigger than priced
2022/Q428 Feb 2023After Market–+0.97%–
2022/Q33 Nov 2022After Market±12.9%-9.43%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q2, ended Jun 2026

Revenue$94.50M+19.3% YoY
Operating profit-$27.39M-23.4% YoY
Net profit-$26.86M-37.2% YoY
Diluted EPS-$0.47-34.3% YoY
Free cash flow-$22.20M-24.4% YoY
Operating cash flow-$19.25M

Revenue, last 8 quarters

$58.4MSep '24$68.2MDec '24$69.2MMar '25$79.2MJun '25$83.3MSep '25$76.4MDec '25$83.1MMar '26$94.5MJun '26

Net profit, last 8 quarters

$-21.0MSep '24$-18.9MDec '24$-24.7MMar '25$-19.6MJun '25$-21.4MSep '25$-29.8MDec '25$-31.6MMar '26$-26.9MJun '26

Profitability & balance sheet

Gross margin64.2%
Operating margin-33.9%
Net margin-32.5%
Return on equity-30.2%
Return on assets-22.1%
Return on invested capital-25.5%
Current ratio6.55
Liabilities / assets29.1%
Cash & investments$227.91M
Total debt$75.00M
Net cash (debt)$152.92M

Discussion

No comments yet — be the first to weigh in on PRCT.

Leave a comment

Scroll to Top